Home GSK Re-files Hepatitis B Drug Bepirovirsen for Marketing Approval in China

GSK Re-files Hepatitis B Drug Bepirovirsen for Marketing Approval in China

May 28, 2026 08:23 CST Updated 12:14
GSK

Pharmaceutical R&D Manufacturer